MEGAN BERARDUCCI: Open Payments
NPI 1427400779 · AKRON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,510 in 171 payments from 34 companies in 2025. Trend: 2023 $18 · 2024 $517 · 2025 $3,510
Food & beverage: $3,510
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 23 | $326 |
| Biogen, Inc. | 9 | $262 |
| TG Therapeutics, Inc. | 6 | $224 |
| ARGENX US, INC. | 5 | $217 |
| ABBVIE INC. | 16 | $211 |
| Genentech USA, Inc. | 14 | $206 |
| HARMONY BIOSCIENCES LLC | 12 | $206 |
| UCB, Inc. | 8 | $187 |
| Lundbeck LLC | 6 | $149 |
| Axsome Therapeutics, Inc. | 5 | $115 |
Products named: INGREZZA, TYSABRI, BRIUMVI, WAKIX, QULIPTA, VYVGART, Ocrevus Zunovo, Briviact.
Industry payments across OH — which companies pay providers there.
